Shareholder Investigation of Bank OZK
Bank OZK (OZK) Accused of Misleading Investors According to the derivative complaint against the company’s officers and directors for breaches of fiduciary duty, unjust enrichment and violations of state and
Bank OZK (OZK) Accused of Misleading Investors According to the derivative complaint against the company’s officers and directors for breaches of fiduciary duty, unjust enrichment and violations of state and
Shareholder Alert: Robbins LLP is Investigating Wanda Sports Group Co. Ltd. (WSG) October 11, 2019 (San Diego, CA & Beijing, China) – Shareholder rights law firm Robbins LLP informs shareholders
Vanda Pharmaceuticals Inc. (VNDA) Used its Drugs for Off-Label Purposes According to the complaint against the company’s officers and directors for breaches of fiduciary duties, unjust enrichment, and waste of
Sonim Technologies, Inc. (SONM) Accused of Misleading Investors in IPO According to the class action complaint against the Company for alleged violations of the Securities Act of 1933, Sonim completed
Corcept Therapeutics Incorporated (CORT) Accused of Illicit Sales Practices According to the complaint against Corcept’s officers and directors for breaches of fiduciary duty, insider selling, and violations of the Securities
Inogen, Inc. (INGN) Accused of Misstating its Strong Sales and Financial Success According to the class action complaint against the company for alleged violations of the Securities Exchange Act of
Ruhnn Holding Limited (RUHN) Accused of Misleading Investors in IPO According to the a class action complaint against the company for alleged violations of the Securities Act of 1933, Ruhnn
Inogen, Inc. (INGN) Accused of Misstating its Strong Sales and Financial Success On November 7, 2017, Inogen, Inc. (INGN) touted its strong sales and financial success, predicting “strong results in
3D Systems Corporation (DDD) In re 3D Systems Corporation Derivative Litigation, Lead Case No. 0:15-cv-03756-MGL (D.S.C.) Stipulation and Agreement of Settlement Notice of Pendency of Derivative Action, Proposed Settlement of
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.